Title : Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment.

Pub. Date : 2019 Jul

PMID : 31295151






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The baseline frequency of intratumoral PD-1 CD8 T cells was significantly lower in patients responding to sorafenib treatment than in the nonresponders (P = 0.0117), and the frequency of circulating PD-1 T cells increased with tumor progression (P = 0.0329). Sorafenib CD8a molecule Homo sapiens